跳至主要内容
临床试验/NCT04994548
NCT04994548已完成不适用

Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension: a Multicenter Observational Study

Central Hospital, Nancy, France0 个研究点目标入组 112 人开始时间: 2005年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
112
主要终点
technical success of early esophageal cancer resection

研究概览

简要总结

Cirrhotic patients may be at high risk for esophageal cancer. Endoscopic resection is the standard treatment for superficial tumors. However, cirrhosis might be associated with upper gastrointestinal bleeding, particularly in case of portal hypertension or coagulopathy. This study aims to assess safety, efficacy and methods to prevent potential complications in cirrhosis or portal hypertension context for esophageal endoscopic resection.

This retrospective multicentric French-Belgian study includes all consecutive patients with cirrhosis or portal hypertension who underwent esophageal endoscopic resection from January 2005 to 2021.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • older than 18 years with cirrhosis or portal hypertension who underwent endoscopic resection of an early esophageal tumor

排除标准

  • younger than 18

结局指标

主要结局

technical success of early esophageal cancer resection

时间窗: baseline

defined by a complete macroscopic resection

次要结局

  • preemptive methods to the risk of bleeding(baseline)
  • morbidity post procedure (delayed bleeding, infection, esophageal stenosis, 30-days related liver decompensation, 30-days related mortality)(up to 4 weeks)
  • adverse events per procedure (immediate bleeding, perforation)(baseline)
  • Potential risk factors for adverse events(baseline)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

相似试验